.ALPHA.-TOCOPHEROL PHOSPHATE, D-

US Previously Marketed

First marketed in 1921

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C29H51O5P
Molecular Weight	510.686
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of .ALPHA.-TOCOPHEROL PHOSPHATE, D-

Structure Search

SMILES

CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(OP(O)(O)=O)=C2C

InChI

InChIKey=JUIUXBHZFNHITF-IEOSBIPESA-N

InChI=1S/C29H51O5P/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(34-35(30,31)32)23(5)24(6)28(26)33-29/h20-22H,9-19H2,1-8H3,(H2,30,31,32)/t21-,22-,29-/m1/s1

HIDE SMILES / InChI

Description
Sources: http://www.google.com/patents/EP0845216A1?cl=en

dl-α-tocopheryl phosphate has a growth acceleration effect on domestic fowl. Also was confirmed, that in all investigated animals dl-α-tocopheryl phosphate has an ability to being converted into vitamin E.

CNS Activity

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
angiogenesis 17 Target ID: GO:0001525 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28571880	Activator 1430
Radical scavenging activity 12 Target ID: CHEMBL613712 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11076575 \| https://www.ncbi.nlm.nih.gov/pubmed/30938183	Activator 1430		19.9 µM [EC50]

Conditions

Condition	Modality	Targets	Highest Phase	Product
Vitamin deficiency 17 Sources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e3912909-50c7-4ad2-49b5-ae3a3dfec758	Preventing		Approved 8429	INFUVITE ADULT Approved Use M.V.I. Adult™ is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and pediatric patients aged 11 and older receiving parenteral nutrition. Launch Date 2000

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Unknown

Name

Type

Language

.ALPHA.-TOCOPHEROL PHOSPHATE, D-

Common Name

English

.ALPHA.-TOCOPHERYL PHOSPHATE, D-

Common Name

English

J313.906I

Code

English

2H-1-BENZOPYRAN-6-OL, 3,4-DIHYDRO-2,5,7,8-TETRAMETHYL-2-((4R,8R)-4,8,12-TRIMETHYLTRIDECYL)-, 6-(DIHYDROGEN PHOSPHATE), (2R)-

Common Name

English

2H-1-BENZOPYRAN-6-OL, 3,4-DIHYDRO-2,5,7,8-TETRAMETHYL-2-((4R,8R)-4,8,12-TRIMETHYLTRIDECYL)-, DIHYDROGEN PHOSPHATE, (2R)-

Common Name

English

D-.ALPHA.-TOCOPHEROL PHOSPHATE

Common Name

English

2H-1-BENZOPYRAN-6-OL, 3,4-DIHYDRO-2,5,7,8-TETRAMETHYL-2-(4,8,12-TRIMETHYLTRIDECYL)-, DIHYDROGEN PHOSPHATE, (2R-(2R*(4R*,8R*)))-

Common Name

English

.ALPHA.-TOCOPHEROL, PHOSPHATE

Common Name

English

Code System Code Type Description

PUBCHEM

94493

Created by admin on Fri Dec 15 18:08:52 GMT 2023 , Edited by admin on Fri Dec 15 18:08:52 GMT 2023

PRIMARY

CAS

71276-50-1

Created by admin on Fri Dec 15 18:08:52 GMT 2023 , Edited by admin on Fri Dec 15 18:08:52 GMT 2023

PRIMARY

EPA CompTox

DTXSID50221445

Created by admin on Fri Dec 15 18:08:52 GMT 2023 , Edited by admin on Fri Dec 15 18:08:52 GMT 2023

PRIMARY

FDA UNII

V7EZ83SETP

Created by admin on Fri Dec 15 18:08:52 GMT 2023 , Edited by admin on Fri Dec 15 18:08:52 GMT 2023

PRIMARY

SALT/SOLVATE (PARENT)


					408UEF2TE8

DISODIUM LAURIMINODIPROPIONATE TOCOPHERYL PHOSPHATE

SUBSTANCE RECORD


					V7EZ83SETP

.ALPHA.-TOCOPHEROL PHOSPHATE, D-

Details

SMILES

InChI

DescriptionSources: http://www.google.com/patents/EP0845216A1?cl=en

CNS Activity

Approval Year

Targets

Conditions

Approved Use

Launch Date

Patents

Sample Use Guides

Description
Sources: http://www.google.com/patents/EP0845216A1?cl=en